This post is presented by our media partner Cannabis News Wire
View the original article here.
The Cannabis Regulators Association (CANNRA) is requesting that the U.S. Drug Enforcement Administration and Biden Administration offer clarity on how rescheduling cannabis will affect enforcement by the federal government, particularly in legal states. In a public comment to the DEA’s administrator Anne Milgram, CANNRA leaders explained that without federal guidance, territorial and state government agencies would be left guessing and hypothesizing about these dynamics and their possible effects on legal programs regulated by states, and the populations impacted by these programs in various jurisdictions, among other things.
CANNRA is an organization that represents hemp and cannabis regulators in more than 45 states and territories in the United States. This nonpartisan organization doesn’t make a stand on the proposal to reschedule the drug but rather, seeks guidance on how the change will impact enforcement priorities, policies, and interactions with local and state officials.
CANNRA also stressed its commitment to supporting its members in the successful implementation of the final regulation on rescheduling. The proposal to reschedule cannabis at the federal level was officially announced in May, with the public comment period coming to an end on July 22, 2024.
In its statement, CANNRA also highlighted areas where guidance related to the drug’s rescheduling was necessary. Apart from its impact on federal enforcement priorities, guidance on requirements and allowance for interstate commerce under the new classification was needed.
The organization noted that it would be important to offer clarity on how marijuana’s rescheduling would impact banking for the marijuana industry as well as current hindrances to research on cannabis. Further federal guidance would also be needed on how cannabinoids would be regulated under the new schedule.
In other news, bipartisan legislators are working to eliminate a section of a spending measure that would block the U.S. Department of Justice from rescheduling cannabis. Representative Nancy Mace revealed last week that she was focused on ensuring rescheduling happens, even though she was more in favor of the drug being fully descheduled.
A similar amendment to the Commerce, Justice, Science and Related Agencies spending resolution was introduced in the House by Representative Rashida Tlaib.
Despite this progress, Republican lawmakers are still trying to block the Biden administration from rescheduling marijuana. Earlier this month, a group of GOP legislators penned a letter discussing their stance against rescheduling the drug. The letter claimed that the proposal wasn’t based on science but on politics.
Senator James Lankford and Representative Pete Sessions led this charge, with the letter being signed by 23 other Senate and House Republican congressional legislators.
This clarity that the state regulators are seeking would also be of great help to marijuana companies such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) since their operations or plans may need to change in light of the change in federal cannabis classification.
About CannabisNewsWire
CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
This post was originally published by our media partner here.
